Sectors
TRDA
Entrada Therapeutics, Inc.
7.05
2 x 5.21
2 x 8.87
bid
ask
+
0.05
0.71%
2 @ 07:30 PM
7.05 +0.00 (0.00%)
| Ytd | -31.42% | |
| 1y | 28.88% |
6.76
day range
7.17
5.02
52 week range
16.45
| Open | 6.84 | Prev Close | 7.00 | Low | 6.76 | High | 7.17 | Mkt Cap | 274.50M |
| Vol | 450.41K | Avg Vol | 346.06K | EPS | -3.96 | P/E | N/A | Forward P/E | -5.54 |
| Beta | -0.27 | Short Ratio | 11.43 | Inst. Own | 80.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 7.07 | 200-d Avg | 9.70 | 1yr Est | 26.43 |
| Income Statement | |||
| Total Revenue | 898.00K | ||
| Revenues (USD) | 898.00K | ||
| Gross Profit | 898.00K | ||
| Operating Expenses | 45.86M | ||
| Research and Development Expense | 35.37M | ||
| Selling, General and Administrative Expense | 10.49M | ||
| Operating Income | -44.96M | ||
| Income Tax Expense | 35.00K | ||
| Net Income | -42.76M | ||
| Net Income Common Stock | -42.76M | ||
| Net Income Common Stock (USD) | -42.76M | ||
| Consolidated Income | -42.76M | ||
| Earnings per Basic Share | -1.01 | ||
| Earnings per Basic Share (USD) | -1.01 | ||
| Earnings per Diluted Share | -1.01 | ||
| Earning Before Interest & Taxes (EBIT) | -42.73M | ||
| Earning Before Interest & Taxes (USD) | -42.73M | ||
| Weighted Average Shares | 42.22M | ||
| Weighted Average Shares Diluted | 42.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 102.57M | ||
| Cash and Equivalents (USD) | 102.57M | ||
| Investments | 123.73M | ||
| Investments Current | 123.73M | ||
| Trade and Non-Trade Receivables | 816.00K | ||
| Current Assets | 232.70M | ||
| Property, Plant & Equipment Net | 62.76M | ||
| Total Assets | 298.88M | ||
| Debt Current | 4.45M | ||
| Total Debt | 48.54M | ||
| Current Liabilities | 21.37M | ||
| Debt Non-Current | 44.10M | ||
| Total Liabilities | 65.47M | ||
| Accumulated Retained Earnings (Deficit) | -355.57M | ||
| Accumulated Other Comprehensive Income | 66.00K | ||
| Shareholders Equity | 233.41M | ||
| Shareholders Equity (USD) | 233.41M | ||
| Assets Non-Current | 66.17M | ||
| Total Debt (USD) | 48.54M | ||
| Deferred Revenue | 173.00K | ||
| Liabilities Non-Current | 44.10M | ||
| Trade and Non-Trade Payables | 3.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 841.00K | ||
| Net Cash Flow from Financing | 350.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 22.84M | ||
| Capital Expenditure | -11.00K | ||
| Issuance (Purchase) of Equity Shares | 350.00K | ||
| Net Cash Flow from Investing | 54.95M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 54.96M | ||
| Net Cash Flow from Operations | -32.46M | ||
| Share Based Compensation | 5.15M | ||